HANCOCK WHITNEY CORP - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 166 filers reported holding ANTARES PHARMA INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q2 2021$186,000
+6.3%
42,743
+0.5%
0.01%0.0%
Q1 2021$175,000
+2.9%
42,5330.0%0.01%0.0%
Q4 2020$170,000
+47.8%
42,5330.0%0.01%
+50.0%
Q3 2020$115,00042,5330.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
WILLIAM HARRIS INVESTORS INC 2,338,735$6,244,0001.73%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,603,703$25,642,0001.03%
Broadfin Capital, LLC 6,100,000$16,288,0000.80%
ASHFORD CAPITAL MANAGEMENT INC 1,088,675$2,907,0000.58%
MARINER INVESTMENT GROUP LLC 296,477$792,0000.15%
THOMPSON DAVIS & CO., INC. 36,500$97,0000.14%
Peregrine Asset Advisers, Inc. 53,034$142,0000.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,165,738$3,101,0000.12%
Avenir Corp 341,035$911,0000.08%
Brown Advisory Securities, LLC 50,550$135,0000.05%
View complete list of ANTARES PHARMA INC shareholders